Markets
Stocks
Mutual Funds & ETF's
Sectors
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
PDL BioPharma, Inc.
(NQ:
PDLI
)
7.690
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
7.920
Bid (Size)
7.380 (800)
Ask (Size)
7.700 (41800)
Prev. Close
7.690
Today's Range
7.680 - 7.940
52wk Range
6.340 - 8.475
Shares Outstanding
139,996,257
Dividend Yield
7.80%
Top News
More News
PDL BioPharma, Inc. (PDLI) Declares $0.15 Quarterly Dividend; 7.7% Yield
June 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8410096 for the full story.
Read More
from
StreetInsider.com News Articles
PDL BioPharma Completes Regular Quarterly Dividend Payment
June 12, 2013
from
PR Newswire
More News
Read More
PDL BioPharma (PDLI) Issues Strong Prelim. Q2 Royalty Revs Outlook
June 11, 2013
from
StreetInsider.com News Articles
PDL BioPharma Provides Second Quarter 2013 Royalty Revenue Guidance of $143 Million
June 11, 2013
from
PR Newswire
PDL BioPharma (PDLI) Files Arbitration Notice Against Genentech Over Royalty Payments
June 11, 2013
from
StreetInsider.com News Articles
PDL Files for Arbitration Against Genentech Based on Underpayment of Royalties
June 11, 2013
from
PR Newswire
Collaborations, Clinical Development Programs, FDA Approvals, New Treatments and Attractive Product Portfolios - Research Report on Medivation, Acadia, Santarus, Seattle Genetics, and PDL BioPharma
June 10, 2013
from
PR Newswire
SEC settles with ex-InterMune controller over tip to friend
June 07, 2013
category
companyNews
from
Reuters: Company News
StockCall Early Morning Insight into AFFY, AMGN, PDLI, QCOR, and BCRX
June 07, 2013
from
ACCESSWIRE
PDL BioPharma Announces Conversion Rate Adjustments for Convertible Notes
June 03, 2013
category
Benzinga
,
PDLI
,
Financing
, and 1 more.
from
Latest Articles from Benzinga.com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here